Sage Therapeutics stock drops
Sage Therapeutics scraps Alzheimer’s drug development after trial fails; shares slide
Sage Therapeutics said on Tuesday it will discontinue the development of its Alzheimer's disease drug as it did not meet the main goal in a mid-stage trial.
Sage Therapeutics’ stock slides after biotech says it will cease development of Alzheimer’s treatment
Sage Therapeutics Inc.’s stock tumbled 12.8% early Tuesday, after the company said a mid-stage trial of a treatment for mild cognitive impairment and mild dementia in Alzheimer’s disease failed to meet its main goal.
Sage Therapeutics Stock Plunges on Disappointing Study Results for Alzheimer’s Treatment
The biopharmaceutical company isn’t planning further clinical development of dalzanemdor to treat Alzheimer’s.
Sage Therapeutics Phase 2 LIGHTWAVE Study In Alzheimer's Disease Fails; Stock Down In Pre-Market
(RTTNews) - Sage Therapeutics, Inc. (SAGE) Tuesday said its Phase 2 LIGHTWAVE study to evaluate dalzanemdor in participants with mild cognitive impairment (MCI) or mild dementia due to Alzheimer's Disease (AD) failed to meet the primary goal. The company's shares were down more than 12 percent in pre-market.
Sage Therapeutics stock drops after disappointing Alzheimer's trial results
Sage Therapeutics shares fell as much as 25% in premarket trading after the company announced disappointing topline results from its Phase 2 LIGHTWAVE study of dalzanemdor (SAGE-718) for the treatment of mild cognitive
Sage Gemini faces sexual assault allegations
FierceBiotech17h
Sage scraps Alzheimer's program as dalzanemdor goes 0 for 2, leaving hopes resting on Huntington's
Sage Therapeutics has seen another clinical trial go up in smoke. | Sage Therapeutics has seen another clinical trial go up ...
BioSpace16h
Sage Suffers Third Neuro Stumble in Six Months With Disappointing Mid-Stage Alzheimer’s Readout
Sage has decided to discontinue the development of dalzanemdor in Alzheimer’s disease. A study of the candidate in Huntington ...
Commercial Observer17h
Sage Realty’s Jonathan Kaufman Iger Wants to Build an Office Brand
The Manhattan owner's inspiration comes from hospitality giants such as Four Seasons and Hilton — and, yes, WeWork.
BioPharma Dive13h
Sage continues downslide as Alzheimer’s study fails
After a series of setbacks for dalzanemdor, some analysts now expect that Sage won’t reach profitability for awhile — and only if its cost structure undergoes significant changes.
Sage + Sound to open its first CT health maintenance studio on Greenwich’s E. Putnam Ave.
New wellness center approved for central Greenwich; Sage + Sound expanding from Manhattan to a location on East Putnam Avenue ...
Sage stock slides as RBC cuts rating to Sell on trial results concerns
RBC Capital Markets cut its rating on SAGE Therapeutics Inc (NASDAQ:SAGE) from Sector Perform to Underperform (Sell), due to ...
ITWeb1d
ATKV transforms operations with Sage Intacct
The implementation has reduced ATKV's month-end reporting time, enhanced financial transparency and allowed teams to access ...
7News Miami2d
Saving Sage Animal Rescue brings 82 cats from Helene-impacted North Carolina to South Florida shelters
Dozens of cats who were in harm’s way have been saved from danger, thanks to a South Florida animal rescue organization.Volunteers<a class="excerpt-read-more" href=" More ...